Founder & President:
Jim Miller, MBA
Jim Miller is the founder and president of PharmSource Information Services, Inc. A preeminent expert in bio/pharmaceutical outsourcing, Jim established and presides over the industry’s principal resource for serious consumers of information on contract drug development and manufacturing, PharmSource STRATEGIC ADVANTAGE. He is editor and publisher of Bio/Pharmaceutical Outsourcing Report and Emerging Markets Outsourcing Report.
Jim serves as an Editorial Advisory Board member for Advanstar Communication’s Pharmaceutical Technology and BioPharm magazines. He writes regular columns on outsourcing for Pharmaceutical Technology, Contract Services Europe and BioPharm magazines. Jim chairs the advisory committee of the Pharma & Biopharma Outsourcing Association (PBOA). He served on the board of directors of the American Type Culture Collection (ATCC) from 2007 until 2016.
Jim formerly was Vice President of Sales and Marketing at Circa Pharmaceuticals, Inc., a solid dose manufacturer. Prior to that, he was President of St. Anthony Publishing, a provider of database information services for the health care industry. He also was a consultant in corporate strategy with the Boston Consulting Group. Jim holds an MBA degree from the Stanford University Graduate School of Business.
Editorial Advisory Board Members:
John Budzinski, PhD
A consultant in sourcing of pharmaceutical products, John is located in West Chester, PA. He formerly was Senior Director of Strategic Sourcing for DuPont Pharmaceuticals, which outsources all of its API and intermediate manufacturing requirements. John has more than 20 years experience in discovery, process development, manufacturing and procurement.
Mak Jawadekar, PhD
An independent pharmaceutical industry consultant, Mak currently serves on several US and international company boards in scientific advisory and business management capacities. After 28 years of tenure at Pfizer Inc., in March 2010, he opted to take early retirement. Mak was a Director, Portfolio Management & Performance with the World Wide Businesses (Commercial) Division of Pfizer Inc. in New London, CT, where he was involved in R&D benchmarking metrics for speed, quality & costs to enhance Pharmaceutical R&D productivity.
Mak also advised Pfizer’s R&D business on system solution approaches and best practices, and served as an advisor to Pfizer’s President of R&D on Asia-related strategic matters. Prior to that, he spent many years with Pfizer’s Pharm Sciences Group as a leader, where he held responsibility for Strategic Outsourcing of Drug Products activities and Drug Delivery Technology Assessment functions. Mak also managed strategic-level decisions on external alliances and collaborations, including partnerships, due diligence activities, and licensing & development. His extensive previous experience includes dosage form development/formulations/drug delivery R&D, clinical manufacturing, tech transfer and scale-up operations, and work with Pfizer Global Manufacturing.
Martin L. Jeiven, MS
Marty is the President of Jeiven Pharmaceutical Consulting, Inc. (JPC), which specializes in clinical materials management. He also presides over Pharmaceutical Training Seminars, Inc., which provides GMP training services. JPC helps its clients identify, audit, and select contract manufacturers and clinical packagers; provides “man in the plant” services during production operations; and provides GMP compliance training. Prior to starting his own company, Marty was Manager of Clinical and Pre-Clinical Materials at RW Johnson Pharmaceutical Research Institute.
Howard L. Levine, PhD
Howard is the President of BioProcess Technology Consultants, a consulting firm specializing in biopharmaceutical process development, manufacturing, and engineering. Previously, Howard was Vice President of Manufacturing Operations at Repligen Corporation, and has worked for Amgen, Genentech, and Xoma. He has lectured extensively on downstream processing and manufacturing in biotechnology.
Paul C. Stuart
Paul has over 20 years of experience in the pharmaceutical industry at Procter and Gamble Company, Inc., and Pfizer, Inc. He has held leadership roles in technical product development, business management, outsourcing management, finance, and supply chain management.
Paul currently serves as Vice President of the Clinical Supply Chain at Pfizer Worldwide R&D, where he is responsible for all drug product manufacturing, inventory management, distribution, and sourcing activities in support of clinical trials global-wide. Paul manages the internal R&D drug product manufacturing assets and inventory facilities, and a broad network of contract service providers in the areas of manufacturing and distribution. His group supports clinical supply needs across all phases of development, including pre-registration programs in Phase I-III, and post-marketing Phase IV studies.
Peter is president of xCell Strategic Consulting, which provides strategy development and operational improvement services to bio/pharmaceutical and other life sciences companies. Peter has held executive leadership roles and provided management consultation within the biopharmaceutical, healthcare and consumer goods industries for over 28 years. His executive positions have included President, North America Commercial Operations and Interim CEO of Patheon, a leading CMO; Sr. Vice President of Manufacturing for Wyeth Pharmaceuticals, and President of the Qualitest division of Endo Pharmaceuticals.
Peter holds a BSME, Mechanical Engineering from Villanova University and a Master’s Degree, Business Administration and Management from Philadelphia University.
PharmSource Professional Staff:
Saul Richmond, D.Phil
Saul is PharmSource’s Director of Market Intelligence. He brings over 15 years of experience in market analysis, having worked in business intelligence roles at Evaluate Pharma, Cardinal Health (now Catalent) and Abbott Laboratories. Prior to that, he was a Post-doctoral fellow in Neuropharmacology at the Universities of Birmingham and Bristol. Saul holds an MSc (Neuroscience) from the Institute of Psychiatry (King’s College London) and a D.Phil in Neuropharmacology from the University of Oxford.
Nathalie McComb, PhD
Nathalie is a Scientific Analyst at PharmSource. Previously, she was a Research Analyst for a CRO and later an Internal Scientific Consultant for a defense law firm specialized in pharmaceutical litigation. Nathalie holds a PhD degree in Pharmacology and Toxicology from the University of Kansas.
Brooke Wilson, BS (Honours)
Brooke is a Senior Research Analyst at PharmSource, and heads the PharmSource Lead Sheet research team. Prior to joining the company in 2005, Brooke was a Scientific Research Assistant for a biotechnology company in Sydney, Australia. Brooke has a BS degree in Biotechnology with Honours from the University of Newcastle, Australia.
Elizabeth (Lisa) Tilley Hinkle, BS
Lisa serves as the Managing Editor at PharmSource. She holds a BS degree in journalism from Radford University, and has over 20 years of experience in editing, writing and managing newsletters and other print media, including B2B publications related to industries including science, pharmaceuticals, biologics and medical devices.
Blythe Moore, BS
Blythe is PharmSource’s Director of Account Management. She heads training and support and helps ensure a close working relationship with clients. A Summa Cum Laude graduate of North Carolina State University, she holds a BS degree in Biological Sciences. She’s had experience with customer service, sales and administration, and has a passion for the biological sciences.
Nathaniel Celentano, BS
Nathaniel is PharmSource’s Business Development Manager. He has a background in the pharma industry, and brings over 3 years of previous BD management experience with a microbiology testing organization. Nathaniel also has experience in project management and customer service. A graduate of Bridgewater College, he holds a BS degree in Allied Health with a focus on Healthcare Management.
Nanthida (Judy) Nanthavong , BS
Judy Nanthavong is a Senior Research Analyst at PharmSource, and specializes in covering events related to medical devices and diagnostics. Prior to joining the company as a full-time, permanent staff member, she previously worked here as a student intern. Judy holds a BS degree in Health Science, Health Systems Management from George Mason University.
Katie Leuth, BA
Katie Leuth is a Senior Research Analyst at PharmSource. She has worked as a QC analyst and as a Lab & Manufacturing Technician, and has experience conducting environmental monitoring of cleanrooms to ensure GMP standards in an R&D facility. Katie also has developed laboratory and manufacturing SOPs and had responsibility for GMP and GLP regulations documentation. She holds a BA degree in Biology from Roger Williams University.
Katie Ludwick, BA
Katie Ludwick is PharmSource’s Marketing Manager. A graduate of George Mason University, she holds a BA degree in Communication with a concentration in Public Relations. In addition to having operational marketing responsibilities, Katie oversees list management and handles production for our monthly e-zine publications PharmSource Periscope and CMC Market Outlook.
Scotty Chung-Siu, BS, MPH
Scotty is a Research Analyst at PharmSource. He holds a BS degree in Biology from George Mason University and an MPH degree from Eastern Virginia Medical School. He’s experienced in data collection, analysis and management, and has done laboratory analysis and safety program development.
Mahdia Hashimy, BS
Mahdia is a Research Analyst at PharmSource. She earned a BS degree in biology from George Mason University, where she minored in business. Prior to this, she received a magna cum laude honors Associates of Sciences degree from Northern Virginia Community College. Mahdia is avidly interested in clinical research and science.
Renée Claire Rothschild, BA
Renée earned a BA (Hons) magna cum laude from the University of the Witwatersrand, South Africa, with a double first in English Literature and Linguistics. She went on to read English as a Flanagan and Overseas (ORS) scholar at the University of Oxford. Renée is specialized in the areas of financial technical analysis, data mining and information synthesis, as well as copy editing.